Document:

EX-10.12

 Exhibit 10.12 

CERTAIN CONFIDENTIAL INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE (I) IT IS NOT MATERIAL AND (II) THE REGISTRANT CUSTOMARILY
AND ACTUALLY TREATS THE INFORMATION AS PRIVATE AND CONFIDENTIAL. 
 TRANSITION SERVICES AGREEMENT 

This TRANSITION SERVICES AGREEMENT (this “Agreement”), dated as May 11, 2020, between Boston Scientific
Corporation, a Delaware corporation, on behalf of itself and the other Sellers (as defined in the Purchase Agreement) (collectively, “Seller”), and Minerva Surgical, Inc., a Delaware corporation, on behalf of itself and its
Affiliates (“Buyer”). 
 W I T N E S S E T H: 

WHEREAS, Buyer, Seller, and the other parties named therein have entered into a certain Asset Purchase Agreement, dated as of
April 28, 2020 (the “Purchase Agreement”) pursuant to which, on the Closing Date, Buyer or its Affiliates are purchasing from the Sellers (as defined in the Purchase Agreement) all of the Purchased Assets; 

WHEREAS, in connection with the transactions contemplated by the Purchase Agreement, Seller has agreed to provide, or procure the
provision of, on the terms and conditions set out in this Agreement, the Seller Services to Buyer for a transitional period following completion of the sale of the Business pursuant to the Purchase Agreement. 

NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and in the Purchase
Agreement, the Parties hereto agree as follows: 
  

	1.	 DEFINITIONS 

1.1    Certain Definitions. Unless otherwise defined in this Agreement, capitalized terms used herein shall have the
meanings given to them in the Purchase Agreement. The following capitalized terms as used in this Agreement shall have the meanings set forth in this Section 1.1: 

“Books, Records and Files” means any studies, reports, records (including shipping records), books of account, invoices,
contracts, instruments, surveys, data (including financial, sales, purchasing and operating data), computer data, disks, diskettes, tapes, marketing plans, customer lists, supplier lists, distributor lists, correspondence and other documents. 

“Confidential Information” means any and all information disclosed by or on behalf of a Party or any of its Representatives
(“Disclosing Party”) to the other Party or any of its Representatives (“Receiving Party”) under or in connection with this Agreement, except information which is: (i) at the time of disclosure, or thereafter
becomes, a part of the public domain through no act or omission by Receiving Party or its Representatives; (ii) lawfully in the possession of Receiving Party prior to disclosure by or on behalf of Disclosing Party as shown by Receiving
Party’s written records (other than by virtue of being a Purchased Asset); (iii) lawfully disclosed to Receiving Party by a third party which did not acquire the same under an obligation of confidentiality from or through Disclosing Party, as
shown by written records; or (iv) independently developed by Receiving Party without use of Disclosing Party’s Confidential Information as shown by Receiving Party’s written records. 

“Law” means, with respect to any Person, any United States federal, state, local or foreign statute, law, ordinance, treaty,
regulation, rule, code, order, directive, settlement agreement, consent decree or other requirement or rule of law that is binding upon or applicable to such Person. 

“Parties” shall be defined as Buyer and Seller. 

“Representatives” means a Person’s employees, officers, directors, Affiliates, subcontractors, agents, successors and
assigns. 
 “Section” means a section of this Agreement, unless the context of this Agreement otherwise requires. 

 “Seller Services” means the services, functions, and tasks provided to
Buyer by or on behalf of Seller specified in Schedule 1 hereto and the schedules attached thereto (as may be amended, modified or supplemented from time to time in accordance with this Agreement), which shall include provisions regarding the
duration and service levels of the Seller Services. 
 1.2    Terms Defined Elsewhere in this Agreement. For
purposes of this Agreement, the following terms have meanings set forth in the Sections indicated below: 
  

					
	 Term
	  	Section	 
	 Agreement
	  	 	Preamble	 
	 Buyer
	  	 	Preamble	 
	 Buyer Indemnified Parties
	  	 	11.2	 
	 Buyer Project Leader
	  	 	5.1	 
	 Charge
	  	 	3.1	 
	 Consent
	  	 	2.5	 
	 Dispute
	  	 	17	 
	 Dispute Notice
	  	 	17	 
	 Extension Notice
	  	 	6.2	 
	 Indemnifiable Losses
	  	 	11.1	 
	 Project Leaders
	  	 	5.1	 
	 Purchase Agreement
	  	 	Recitals	 
	 Seller
	  	 	Preamble	 
	 Seller Indemnified Parties
	  	 	11.1	 
	 Seller Project Leaders
	  	 	5.1	 
	 Term
	  	 	6.1	 

  

	2.	 TRANSITION SERVICES 

2.1    During the Term, Seller shall provide the Seller Services to Buyer at Buyer’s expense, with such expenses
specifically provided on Schedule 1 hereto, in exchange for the consideration set forth in this Agreement. 

2.2    Seller shall be responsible for the actions of its Affiliates in connection with the provision of services or
performance of obligations under or in connection with this Agreement. Notwithstanding anything herein to the contrary, in no event shall Seller or any of its Affiliates be required to perform, or cause to be performed, any service in a manner that
would constitute a violation of Law or of Seller’s policies. Additionally, in no event shall Seller or any of its Affiliates be required to perform, or cause to be performed, any service for the benefit of a third party. 

2.3    With respect to the Seller Services, Seller shall have the exclusive right to select, employ, pay, supervise,
administer, direct and discharge any of the employees or contractors who will perform the Seller Services, provided, that Seller shall provide Buyer a reasonable opportunity to object to the selection or discharge of such employees or
contractors, and Seller shall take into consideration Buyer’s objections in good faith. 
 2.4    In the event of a
conflict between a provision of this Agreement and the schedules hereto (including Schedule 1), the terms of the schedules shall govern. 

2.5    Seller has obtained all consents, approvals or agreements of any third party (each, a “Consent”)
required for Seller to provide the Seller Services as of the Closing Date pursuant to this Agreement (or to use any equipment or software owned by or leased or licensed to Seller in connection with the provision of such Seller Services), and no
further Consent to provide the Seller Services hereunder is required, except where the failure to obtain such Consent will not interfere in any material respect with Seller’s ability to provide the Seller Services hereunder. 

  
 2 

 2.6    Seller makes no representations and warranties of any kind,
implied or expressed, with respect to the Seller Services, including, without limitation, any warranties of merchantability or fitness for a particular purpose, which are specifically disclaimed. 

 

	3.	 BILLING; TAXES 

3.1    With respect to any Seller Service for which (a) reasonable and documented out-of-pocket third-party costs or expenses are incurred by or on behalf of Seller or (b) any fees, costs, charges or expenses are set forth on Schedule 1 (collectively,
“Charges”), unless otherwise specified in Schedule 1 for such Seller Service: (i) Charges shall be invoiced by Seller on a monthly basis in arrears; (ii) invoiced amounts shall be paid by Buyer within thirty
(30) days of receipt of the invoice; (iii) Charges shall be invoiced and paid in U.S. dollars; and (iv) invoices shall be sent to the address specified in Section 13.1 hereto and payments shall be directed to
the account specified in writing by Seller from time to time. 
 3.2    Buyer shall pay any and all Taxes incurred in
connection with Seller’s provision of the Seller Services, including all withholding Taxes required by Law and all sales, use, value-added, and similar Taxes, but excluding Taxes based on Seller’s net income. If any such withholding Taxes
are required by Law, then the sum payable by Buyer shall be increased as necessary so that after such withholding has been made (including withholding applicable to additional sums payable under this Section 3.2), Seller
receives an amount equal to the sum it would have received had no such withholding been made. The Parties agree to reasonably cooperate in good faith to attempt to (i) minimize or avoid Taxes incurred in connection with Seller’s provision
of the Seller Services (ii) obtain any applicable Tax exemptions or Tax refunds. 
 3.3    Buyer’s obligation
to make any required payments under this Agreement shall not be subject to any unilateral right of offset, set-off, deduction or counterclaim, however arising. 

 

	4.	 COOPERATION 

4.1    During the Term of this Agreement, Buyer shall, subject to compliance with applicable Laws and all of Buyer’s
safety and security procedures and directives which are generally applicable to third parties visiting Buyer’s facilities, provide Seller and its Affiliates (including third-party service providers) with any assistance, information, and access
to personnel and facilities as Seller and its Affiliates (including third-party service providers) may reasonably request to enable Seller to perform its obligations, and enjoy its benefits, under this Agreement. Such access will be during
Buyer’s normal business hours, as may be reasonably requested by Seller upon reasonable prior written notice. 

4.2    During the Term of this Agreement, Seller shall, subject to compliance with applicable Laws and all of
Seller’s safety and security procedures and directives which are generally applicable to third parties visiting Seller’s facilities, provide Buyer and its Affiliates (including third-party service providers) with any assistance,
information, and access to personnel and facilities as Buyer and its Affiliates (including third-party service providers) may reasonably request to enable Buyer to perform its obligations, and enjoy its benefits, under this Agreement. Such access
will be during Seller’s normal business hours, as may be reasonably requested by Buyer upon reasonable prior written notice. 
  

	5.	 PROJECT MANAGEMENT 

5.1    Each Party hereto has appointed or shall appoint one or two representatives who shall be the authorized
representatives of that Party and empowered to act on its behalf in connection with this Agreement (the “Project Leaders”). Buyer’s initial Project Leaders shall be Dominique Filloux (the “Buyer Project
Leaders”) and Seller’s initial Project Leaders shall be Bryan Maloney (the “Seller Project Leaders”). Each Party hereto shall notify the other in writing promptly in the event of any change to those appointments. 

  
 3 

 5.2    The Project Leaders shall be employed by Buyer or Seller (or one
of its Affiliates), as applicable, shall devote the time and effort necessary to manage the Seller Services, will serve as the point of accountability to the opposite Party for the provision or use, as the case may be, of the Seller Services, and
will have day-to-day responsibility for the provision and use of the Seller Services and for ensuring the smooth and efficient operation of this Agreement. 

5.3    The Project Leaders shall use reasonable efforts to resolve in an amicable and cooperative manner issues which are
raised by either of the Parties hereto in relation to this Agreement. If such Project Leaders are unable to resolve any issue, the dispute resolution procedure set out in Section 17 shall apply. 

 

	6.	 TERM 

6.1    The term (“Term”) of this Agreement shall commence on the date hereof and shall continue for a
period ending on the earlier of (i) as to any particular Seller Service, the time period set forth for such Seller Service in Schedule 1 hereto, and (ii) the date on which all Seller Services either have been terminated under
Section 7 or are no longer being provided because their terms have expired. 

6.2    Notwithstanding Section 6.1, the Term of any particular Seller Service set forth on
Schedule 1(b) hereto may be extended by Buyer by providing Seller with a written notice of such extension (an “Extension Notice”) no later than forty-five (45) days prior to the expiration of such Term (provided,
that the Parties shall endeavor in good faith to discuss Buyer’s anticipated need for such extension not later than sixty (60) days prior to the expiration of such Term, or the applicable notice period required by Schedule 1(b)
hereto, whichever is less, during which discussion Buyer shall offer its non-binding, good faith estimate of the need, if any, to extend such Seller Service), provided that Buyer may extend the Term for any
Seller Service only the number of times expressly permitted for such Term as set forth in Schedule 1(b) hereto unless otherwise mutually agreed to in writing by the parties. The Extension Notice shall set forth the term of the extension,
provided that such extension period shall not exceed the permitted extension period for such Seller Service as set forth in Schedule 1(b) hereto. For the avoidance of doubt, only Seller Services set forth on
Schedule 1(b) hereto may be extended. 
  

	7.	 TERMINATION 

7.1    Buyer has the right to terminate any or all of the Seller Services (or any portion thereof) provided by Seller under
this Agreement on forty-five (45) calendar days’ prior written notice to Seller. 
 7.2    Each Party hereto
shall have the right, without prejudice to its other rights or remedies, to terminate this Agreement immediately by written notice to the other if the other Party hereto: 

(a)    is in material breach of any of its obligations under this Agreement and either that breach is incapable of remedy
or such other Party shall have failed to remedy that breach within thirty (30) days after receiving written notice from the other Party requiring it to remedy that breach; or 

(b)    is unable to pay its debts or becomes insolvent or an order is made or a resolution passed for the administration, winding-up or dissolution of the other Party (otherwise than for the purposes of a solvent amalgamation or reconstruction) or an administrative or other receiver, manager, liquidator, administrator, trustee or
similar officer is appointed over all or any substantial part of the assets of the other Party or the other Party enters into or proposes any composition or arrangement with its creditors generally or anything analogous to the foregoing occurs in
any applicable jurisdiction. 

  
 4 

 7.3    Promptly following the termination of this Agreement, Seller
shall transfer or cause to transfer the Books, Records and Files received or created by Seller primarily for the benefit of Buyer during the provision of the Seller Services, in the format such Books, Records and Files were created or received, and
maintained by Seller in the ordinary course. Notwithstanding anything to the contrary contained herein, Seller may redact any information not related to the Seller Services from any Books, Records and Files conveyed pursuant to this
Section 7.3; provided, however, that such redaction shall not impair any information related to the Seller Services contained in such Books, Records and Files. 

7.4    Upon termination of any Seller Service pursuant to this Agreement, Seller will have no further obligation to
provide the terminated service, and Buyer will have no obligation to pay any future Charges relating to any such terminated service; provided, however, that Buyer shall remain obligated to Seller for Charges owed and payable in respect of any Seller
Services provided prior to the effective date of such termination. In connection with termination of any Seller Service, the provisions of this Agreement not relating solely to such terminated service shall survive any such termination, and in
connection with a termination of this Agreement, the provisions set forth in Section 16 shall continue to survive indefinitely. 
  

	8.	 CONFIDENTIALITY 

8.1     During the Term and for a period of five (5) years thereafter, Receiving Party shall not, without the prior
written consent of Disclosing Party, disclose any Confidential Information to anyone for any reason at any time, except as expressly permitted under this Agreement. Receiving Party shall not, without the prior written consent of Disclosing Party,
use any Confidential Information for any purpose except to exercise its rights and perform its obligations expressly set forth herein or as requested in writing by Disclosing Party. If Receiving Party believes in good faith that it is required by
the law of any relevant jurisdiction or pursuant to an order of a court of competent jurisdiction or that of a competent Governmental Authority to disclose any Confidential Information, it shall assert the confidential nature of the Confidential
Information to the authority, shall provide written notice to Disclosing Party, to the extent possible, prior to making such disclosure, and shall reasonably cooperate with the Disclosing Party, at the Disclosing Party’s expense, so as to allow
Disclosing Party time to undertake legal or other action, to prevent such disclosure or otherwise obtain confidential treatment of such disclosure. In no event will Receiving Party disclose any Confidential Information that Receiving Party is not
compelled to disclose by law, and Receiving Party will exercise reasonable efforts, at the Disclosing Party’s expense, to obtain assurance that confidential treatment will be accorded to any Confidential Information so disclosed. Both Parties
shall take precautions with the other Party’s Confidential Information as each normally takes with its own confidential and proprietary information of a similar nature to prevent disclosure to third parties, but no less than reasonable
precautions. 
 8.2     Receiving Party shall limit dissemination of Confidential Information to only those of Receiving
Party’s Representatives having a “need to know”, advise each such Representative who receives Confidential Information that such information is confidential, and require each such Representative (other than attorneys and other agents
who are already under a professional duty of confidentiality) to be bound by obligations of confidentiality, non-use and non-disclosure with respect thereto at least as
restrictive as those set forth in this Agreement. Each party further acknowledges that Disclosing Party’s disclosure of Confidential Information (including that which is a process, machine, manufacture, or composition of matter) is not intended
to be an offer for sale or public use. Receiving Party shall not by virtue of this Agreement, obtain any title to, or any interest or license in, any Confidential Information, except as contemplated in this Agreement. 

  
 5 

 8.3    Upon written demand by Disclosing Party, and in any event upon
termination of this Agreement, the Receiving Party shall: (i) cease using the Confidential Information; (ii) return or destroy the Confidential Information furnished by or on behalf of Disclosing Party and destroy all notes or extracts
prepared by Receiving Party or its Representatives containing any Confidential Information, provided that, Receiving Party shall be permitted to retain one (1) copy of all Confidential Information to the extent that such retention is
required, or expected to be required, to demonstrate compliance with applicable Law, and that copy shall be subject to the terms of this Section 8; and (iii) upon request of Disclosing Party, confirm in writing to such
return or destruction; and provided further that the Receiving Party will not be required to erase electronically stored Confidential Information that has been saved to a backup file in accordance with its ordinary backup and archiving
procedures. 
 8.4    Neither Party shall issue a press release or other public announcement or public disclosure
concerning this Agreement, the transactions contemplated herein, or the relationship between the Parties without the prior written approval of an authorized representative of the other Party. 

 

	9.	 PERSONNEL 

9.1     For the avoidance of doubt, no provision of the Seller Services by Seller or by any employee or former employee of
Seller shall require any person to become or be deemed to have become an employee of Buyer. All employees of Seller engaged in the provision of the Seller Services shall remain the employees of Seller for the duration of this Agreement, subject
always to Seller’s right, and the respective employees’ rights, to terminate their employment. 
  

	10.	 REPRESENTATIONS, WARRANTIES AND COVENANTS 

10.1    EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY
EXPRESSLY DISCLAIMS ALL OTHER REPRESENTATIONS AND WARRANTIES, EXPRESS OR IMPLIED IN FACT OR BY OPERATION OF LAW, STATUTORY OR OTHERWISE, UNDER THIS AGREEMENT. 
  

	11.	 INDEMNIFICATION 

11.1    Seller shall indemnify, defend and hold harmless Buyer and each of its Affiliates, and each of their respective
officers, directors, agents, successors and assigns of any of the foregoing (the “Buyer Indemnified Parties”) from and against all losses, damages, claims, awards, judgments, penalties, costs and expenses (including reasonable
attorney’s fees) (the “Indemnifiable Losses”) suffered or incurred by them to the extent arising out of or resulting from any material breach by Seller of this Agreement, except to the extent such Indemnifiable Losses arise out
of the gross negligence or willful misconduct of any Buyer Indemnified Party; provided, however, that in no event shall any Buyer Indemnified Party be entitled to indemnification for any special, indirect, incidental or consequential
damages (including without limitation damages for lost profits or based on a multiple of earnings) except to the extent awarded to a third party in an indemnifiable third-party claim. 

11.2    Buyer shall indemnify, defend and hold harmless Seller and each of its Affiliates, and each of their respective
officers, directors, agents, successors and assigns of any of the foregoing (the “Seller Indemnified Parties”) from and against all Indemnifiable Losses suffered or incurred by them to the extent arising out of or resulting from any
material breach by Buyer of this Agreement, except to the extent such Indemnifiable Losses arise out of the gross negligence or willful misconduct of any Seller Indemnified Party; provided, however, that in no event shall any Seller
Indemnified Party be entitled to indemnification for any special, indirect, incidental or consequential damages (including without limitation damages for lost profits or based on a multiple of earnings) except to the extent awarded to a third party
in an indemnifiable third-party claim. 

  
 6 

	12.	 FORCE MAJEURE 

12.1    Any delay in the performance of any of the duties or obligations of either Party shall not be considered a breach
of this Agreement and the time required for performance shall be extended for a period equal to the period of such delay only if such delay has been caused by or is the result of any acts of God; acts of a public enemy; insurrections; riots;
embargoes; labor disputes (including strikes, lockouts, job actions, or boycotts); fires; explosions; floods; shortages of material or energy or other unforeseeable causes; in each case, that are beyond the reasonable control and without the fault
or negligence of the Party so affected. The Party so affected shall give prompt written notice to the other Party of such cause, and shall take whatever reasonable steps are necessary to relieve the effect of such cause as rapidly as reasonably
possible. 
  

	13.	 NOTICES 

13.1    Unless otherwise specifically provided herein, all notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by an internationally recognized overnight courier service, by facsimile, by e-mail or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties hereto at the following addresses (or at such other address for a party as shall be specified in a
notice given in accordance with this Section 13.1): 
 If to Buyer: 

Minerva Surgical, Inc. 
 Prior to
April 15, 2020: 
 101 Saginaw Drive 

Redwood City, CA 94063 
 On or
after April 15, 2020: 
 4255 Burton Drive 

Santa Clara, CA 95054 
 with a
copy to (which shall not constitute notice): 
 Wilson Sonsini Goodrich & Rosati 

650 Page Mill Road 
 Palo Alto, CA
94304 
 and 
 Wilson Sonsini
Goodrich & Rosati 
 One Market Plaza 

Spear Tower, Suite 3300 
 San
Francisco, CA 94105 

  
 7 

 If to Seller: 

Boston Scientific Corporation 

300 Boston Scientific Way 

Marlborough, MA 01752 

Attention: Chief Financial Officer 

with a copy to (which shall not constitute notice): 

Boston Scientific Corporation 

300 Boston Scientific Way 

Marlborough, MA 01752 
 Attention:
Chief Corporate Counsel 
 All such notices, requests, demands, consents and other communications shall be deemed to have been duly given or sent three
(3) days following the date on which mailed, or one (1) day following the date mailed if sent by overnight courier, or on the date on which delivered by hand or by email or facsimile transmission (receipt confirmed), as the case may be,
and addressed as set forth above. 
  

	14.	 BINDING EFFECT; ASSIGNMENT 

14.1    This Agreement shall be binding upon and inure to the benefit of each of the Parties and their respective
Affiliates, heirs, successors and permitted assigns. No assignment, pledge or other transfer of this Agreement or of any rights, interests or obligations hereunder may be made by Buyer or Seller (by operation of Law or otherwise) without the prior
written consent of the other Party and any attempted assignment, pledge or transfer without the required consent shall be void. Such consent shall not be unreasonably withheld, conditioned or delayed. No assignment, pledge or transfer of any
obligations under this Agreement shall relieve the Parties of any such obligations. Notwithstanding the foregoing, (a) either Party shall be entitled to assign this Agreement to such Party’s Affiliates, provided that such Party
shall remain jointly and severally liable with such Affiliate for the performance of the obligations assumed by such Affiliate, (b) Buyer shall be entitled to assign this Agreement following the Closing, to a third party acquiring all or
substantially all of the Business or to any successor entity of Buyer in connection with a merger or sale of substantially all the assets or capital stock of Buyer and (c) Seller shall be entitled to assign this Agreement following the Closing,
to a third party acquiring all or substantially all of Parent’s urology and pelvic heath division or to any successor entity of Parent in connection with a merger or sale of substantially all the assets or capital stock of Parent;
provided that in the cases of (b) and (c), such third party agrees in writing to assume all obligations of Buyer or Parent, as the case may be, pursuant to this Agreement. 

 

	15.	 GENERAL 

15.1    Relationship of the Parties. The Parties hereto are independent contractors and neither Party is a
fiduciary, employee, partner, joint venture or agent of the other. Under no circumstances shall any of the employees of a Party hereto be deemed to be employees of the other Party for any purpose. Neither Party shall have the right to bind the other
to any agreement with a third party nor to represent itself as a partner, joint venturer or agent of the other by reason of this Agreement. 

15.2    Counterparts. This Agreement may be executed in any number of counterparts and by the Parties in separate
counterparts, and delivered by facsimile or other means of electronic transmission (including by .PDF format), each of which shall be deemed to be one and the same instrument and an original document. 

  
 8 

 15.3    Severability. If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any Law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect for so long as the economic or legal substance of the
transactions contemplated by this Agreement is not affected in any manner materially adverse to either party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto
shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated by this Agreement are consummated as originally
contemplated to the greatest extent possible. 
 15.4    Entire Agreement. This Agreement, the Purchase Agreement
and the Ancillary Agreements constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof and supersede all prior agreements and undertakings, both written and oral, between Seller and Buyer with
respect to the subject matter hereof and thereof. 
 15.5    Amendment. This Agreement may not be amended or
modified except (a) by an instrument in writing signed by, or on behalf of, Buyer and Seller or (b) by a waiver in accordance with Section 15.7. 

15.6    Waiver. Either party to this Agreement may (a) extend the time for the performance of any of the
obligations or other acts of the other party, (b) waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered by the other party pursuant hereto or (c) to the extent
permitted by applicable Law, waive compliance with any of the agreements of the other party or conditions to such party’s obligations contained herein. Any such extension or waiver shall be valid only if set forth in an instrument in writing
signed by the party to be bound thereby. Any waiver of any term or condition shall not be construed as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any other term or condition of this
Agreement. The failure of either party hereto to assert any of its rights hereunder shall not constitute a waiver of any of such rights. 

15.7    No Third Party Beneficiaries. This Agreement shall be binding upon and inure solely to the benefit of the
parties hereto and their respective successors and permitted assigns and nothing herein is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, including any rights of employment
for any specified period, under or by reason of this Agreement. 
 15.8    Other Remedies; Specific
Performance. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by Law or equity upon such party, and the
exercise by a party of any one remedy will not preclude the exercise of any other remedy. The parties hereto agree that irreparable damage would occur in the event that any provision of this Agreement is not performed in accordance with its specific
terms or is otherwise breached. It is accordingly agreed that the parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any court of the
United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at Law or in equity. 

15.9    Expenses. Except as otherwise specifically provided herein, each Party shall be responsible for such
expenses as it may incur in connection with the negotiation, preparation, execution, delivery, performance and enforcement of this Agreement. 

15.10    Interpretive Rules. The words “hereof,” “herein” and “hereunder” and words
of similar import when used in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement, and all Section references are to this Agreement unless otherwise specified. The words “include,”
“includes” and “including” will be deemed to be followed 

  
 9 

 
by the phrase “without limitation.” The word “days” means calendar days unless otherwise specified herein. The headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation of this Agreement. No provision of this Agreement shall be construed to require a party or its respective officers, directors, or Affiliates to take any action that would violate or
conflict with any applicable Law. The word “if” means “if and only if.” The word “or” shall not be exclusive. The meanings given to terms defined herein will be equally applicable to both the singular and plural forms
of such terms. Whenever the context may require, any pronoun includes the corresponding masculine, feminine and neuter forms. Except as otherwise expressly provided herein, all references to “dollars” or “$” will be deemed
references to the lawful money of the United States of America. 
 15.11    Title To Intellectual Property. Buyer
acknowledges that it shall acquire no right, title or interest (including any license rights or rights of use) in any intellectual property that is owned or licensed by Seller, by reason of the provision of the Services provided hereunder. Buyer
shall not remove or alter any copyright, trademark, confidentiality or other proprietary notices that appear on any intellectual property owned or licensed by Seller, and Buyer shall reproduce any such notices on any and all copies thereof. Buyer
shall not attempt to decompile, translate, reverse engineer or make excessive copies of any intellectual property owned or licensed by Seller, and Buyer shall promptly notify Seller of any such attempt, regardless of whether by Buyer or any third
party, of which Buyer becomes aware. Nothing in this Agreement shall affect any rights granted to a party under the Purchase Agreement. 
  

	16.	 SURVIVAL 

The provisions of Sections 1, 7.3, 8, 10, 11, and Sections 13 through 19, shall survive the
expiration or earlier termination of this Agreement for any reason whatsoever. 
  

	17.	 DISPUTE RESOLUTION 

Any dispute, claim or controversy arising out of or in connection with this Agreement (“Dispute”), shall be referred by either
Party first to the Project Leaders of each of the Parties for resolution, except in the event of a Dispute involving fraud or willful misconduct. If the Dispute cannot be resolved by such Project Leaders of the Parties within fourteen (14) days
after the Dispute has arisen, either Party may give notice to the other Party in writing (“Dispute Notice”) that a Dispute has arisen. Within seven (7) days after the date of the Dispute Notice, the Dispute shall be referred to
a senior executive of each of Buyer and Seller for resolution. If the Dispute is not resolved by agreement in writing between the Parties within fourteen (14) days after the date of the Dispute Notice, the Dispute may be resolved in accordance
with Section 19. 
  

	18.	 GOVERNING LAW 

This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts executed in
and to be performed in that state, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other
than the State of Delaware. 
  

	19.	 ARBITRATION. 

19.1    Any claim or dispute arising under or relating to this Agreement, including disputes related to the validity,
interpretation or enforcement of any provision this Agreement, shall be finally settled under the JAMS Comprehensive Arbitration Rules and Procedures by a panel of three arbitrators, unless the parties otherwise mutually agree to a panel of one
arbitrator (the “Panel”). Should the parties agree to a panel of three arbitrators, Buyer and Seller shall each select one arbitrator to represent them, and such two arbitrators together shall select a third arbitrator for the
proceedings. The place of arbitration shall be San Mateo, California. The arbitration shall be conducted in the English language. 

  
 10 

 19.2    The Panel shall render an award within one (1) month from
the date of the appointment of the Panel, unless the parties to this Agreement otherwise agree in writing or the Panel determines that an extension is necessary. The arbitral award shall be in writing, state the reasons for the award, and be final
and binding upon, and non-appealable by, the parties to this Agreement. To the extent as would be permitted under the JAMS Comprehensive Arbitration Rules and Procedures, the Panel shall be empowered to grant
default and/or summary judgments. In addition to monetary damages, the Panel shall be empowered to award equitable relief, including, but not limited to, an injunction and specific performance of any obligation under this Agreement. Notwithstanding
the foregoing, the parties to this Agreement agree that any of them may seek equitable relief, including, but not limited to, an injunction and specific performance of any obligation under this Agreement from any court of competent jurisdiction, but
that the final resolution of any disputes will be settled solely by the Panel. 
 19.3    The parties to this Agreement
agree that the arbitration shall be kept confidential and that the existence of the proceeding and any element of it (including but not limited to any pleadings, briefs or other documents submitted or exchanged, any testimony or other oral
submissions, and any awards) shall not be disclosed beyond the Panel, the parties, their counsel and any person necessary to the conduct of the proceeding, except as may be lawfully required in judicial proceedings relating to the arbitration or
otherwise, or as required by the rules of any other quotation system or exchange on which the disclosing party’s securities are listed or applicable Law. 

19.4    Each party to this Agreement agrees not to assert (by way of motion, as a defense or otherwise), in any such
dispute that any claim arising out of, relating to, or in connection with the interpretation or performance of this Agreement is not subject to the jurisdiction of the Panel or that this Agreement may not be enforced by the Panel. 

 

	20.	 CONSENT TO JURISDICTION; WAIVER OF JURY TRIAL. 

 

	 	(a)	 EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE STATE COURTS OF THE
STATE OF DELAWARE AND TO THE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE, FOR THE PURPOSE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT AND EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY
AGREES THAT ALL CLAIMS IN RESPECT TO SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED EXCLUSIVELY IN ANY DELAWARE STATE OR FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY ACTION OR PROCEEDING SHALL BE CONCLUSIVE
AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. 

  

	 	(b)	 EACH OF THE PARTIES HERETO IRREVOCABLY CONSENTS TO THE SERVICE OF THE SUMMONS AND COMPLAINT AND ANY OTHER
PROCESS IN ANY OTHER ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, ON BEHALF OF ITSELF OR ITS PROPERTY, BY THE PERSONAL DELIVERY OF COPIES OF SUCH PROCESS TO SUCH PARTY PURSUANT TO SECTION
13. NOTHING IN THIS SECTION 19 SHALL AFFECT THE RIGHT OF ANY PARTY TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 

  
 11 

	 	(c)	 EACH OF THE PARTIES HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY RIGHT TO TRIAL BY JURY OF
ANY CLAIM, DEMAND, ACTION, OR CAUSE OF ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES IN RESPECT OF
THIS AGREEMENT OR ANY OF THE TRANSACTIONS RELATED TO THIS AGREEMENT, IN EACH CASE, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER IN CONTRACT, TORT, EQUITY, OR OTHERWISE. EACH PARTY HEREBY FURTHER AGREES AND CONSENTS THAT ANY SUCH CLAIM,
DEMAND, ACTION, OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY AND THAT THE PARTIES MAY FILE A COPY OF THIS AGREEMENT WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE PARTIES TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.
EACH OF THE PARTIES HERETO HEREBY (I) CERTIFIES THAT NO REPRESENTATIVE OF THE OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, AND
(II) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AS APPLICABLE, BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 19.

 [The remainder of this page is intentionally left blank.] 

  
 12 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be executed by their
respective authorized officers as of the date first written above. 
  

			
	MINERVA SURGICAL, INC.

 
			
		
	By:	 	 /s/ David Clapper

 

			
	Name: David Clapper
	Title: President and Chief Executive Officer

  

			
	BOSTON SCIENTIFIC CORPORATION

 
			
		
	By:	 	 /s/ Vance Brown

 
			
	Name: Vance Brown
	Title: Vice President and Chief Corporate Counsel

 [Signature page to Transition Services Agreement] 

 SCHEDULE 1 

Seller Services and Term 

 SCHEDULE 1 

[***] 

  
 1EX-10.13

 Exhibit 10.13 

LICENSE AGREEMENT 
 This
License Agreement (“Agreement”) is made and entered into effective October 31, 2008 (“Effective Date”), by and between Hermes, LLC, a Delaware limited liability company (hereinafter “Licensor”) and Minerva Surgical,
Inc., a Delaware corporation having an address at (hereinafter “Licensee”). Each of the Licensor and Licensee are each hereinafter referred to individually as a “Party” and collectively as the “Parties.” 

WHEREAS, Csaba Truckai (“Truckai”) is a managing member of Licensor, and is an inventor of a certain patent set forth in
Exhibit A related to systems and methods for tissue ablation enabled by conduction of energy through a plasma within or about an instrument working end; 

WHEREAS, Truckai has transferred all of his right, title, and interest in and to the patent listed in Exhibit A to Licensor; 

WHEREAS, Licensor is the owner of the patent listed in Exhibit A; 

WHEREAS, Licensee desires to have, and Licensor desires to grant Licensee, an exclusive license to rights to Patents (defined below) and in
the Field of Use (defined below) on the terms and conditions set forth below; and 
 NOW, THEREFORE, in consideration of the promises and
the mutual covenants contained herein, the Parties hereto agree as follows: 
 1. DEFINITIONS 

For the purpose of this Agreement, the following words and phrases shall have the meanings set forth below: 

1.1 “Control” means, with respect to an item of information or know-how or Patents or
Patents Rights, possession by the Party granting the applicable license of the power and authority, whether arising by ownership, license, or other authorization, to disclose and deliver the particular item of information or know-how to the other Party, and to grant and authorize under such information or know-how or Patents or Patent Rights the licenses, and sublicenses, as applicable, of the
scope granted to such other Party in this Agreement without giving rise to any of the following: (i) a violation of the terms of any written agreement with any third party; (ii) a violation or infringement of any Intellectual Property
Right of any third party; (iii) the granting Party being required to pay any royalty or other consideration to any third party that would not have been required had a license not been provided under this Agreement; (iv) a violation of any
law, regulation, rule, code, order or other requirement of any governmental authority or the need for any additional permits, payments, authorizations, or approvals under any applicable law. 

 1.2 “Confidential Information” shall mean: (a) with respect to a Party (the
“Receiving Party”), all confidential information (including any and all ideas, inventions, discoveries, unpublished patent applications, confidential information, biological materials, data, results, formulae, designs, specifications,
devices, methods, processes, manufacturing data, techniques, ideas, know-how, technical information including, without limitation, structural and functional information, development plans and schedules,
marketing and sales information, clinical and preclinical information and results, specifications, and protocols, financial information, customer lists), which is disclosed by the other Party (the “Disclosing Party”) to the Receiving Party
hereunder or to any of its employees, consultants or Affiliates; and which is designated as confidential information, prior to, dining or immediately after disclosure. All disclosures shall be reduced to writing, marked confidential, and provided to
the Receiving Party having such designation within thirty (30) days after the initial disclosure thereof. Confidential Information does not include information described in this Section 1.1, which (i) as of the date of disclosure is
demonstrably known to the Receiving Party or its Affiliates, as shown by written documentation, other than by virtue of a prior confidential disclosure to such Party by the Disclosing Party; (ii) as of the date of disclosure is in, or
subsequently enters, the public domain, through no fault or omission of the Receiving Party; (iii) is obtained from a third party having a lawful right to make such disclosure free from any obligation of confidentiality to the Disclosing Party;
or (iv) is independently developed by or for the Receiving Party without reference to, or reliance upon, any confidential information of the Disclosing Party as demonstrated by competent written records. 

1.3 “Field of Use” shall mean medical devices for treating a female patient’s uterus and/or fallopian tubes, including but not
limited to treatments for endometrial ablation, fibroids, polyps, and other uterine tumors, and treatments for closure of fallopian tubes. 

1.4 “Intellectual Property Rights” shall mean any and all intellectual property and industrial property rights and all other
proprietary rights; including, without limitation, trade secrets, trademarks, copyrights, Patents, and all registrations and applications of any of the foregoing. 

1.5 “Improvements” with respect to any Patent Rights shall mean any and all modifications, enhancements, improvements, additions,
alterations, developments, discoveries, and refinements made to or based on such Patent Rights owned or Controlled by Licensor during the Term that are necessary to practice the Technology in the Field of Use, in each case that are made by or on
behalf of a Party during the period beginning on the Effective Date and expiring on the third (3rd) anniversary thereof. 

1.6 “License/Licensed” shall mean the license described in Section 4.1 below. 

1.7 “Licensed Products” shall mean any and all systems, system components, products, processes and methods that, when manufactured,
used, practiced, offered for sale, imported, sold or distributed, would infringe a Valid Patent Claim, but for the License. 
 1.8
“Licensee Improvements” shall mean Improvements Controlled by Licensee. 
 1.9 “Licensor Improvements” shall mean
Improvements Controlled by Licensor. 
 1.10 “Patents” shall mean any and all patents and patent applications, including any
provisionals, divisionals, substitutions, inventor certificates, utility models, continuations, continuations-in-part, reissues, reexaminations, or extensions thereof,
supplementary protection certificates, renewals, all letters patents granted on or claiming priority to any of the foregoing applications, and all foreign and international counterparts of the foregoing filed, granted, or issued in any country or
jurisdiction. 

  
 2 

 1.11 “Patent Rights” shall mean the patents and patent applications identified in
Exhibit A; and continuing applications, divisions and substitutions, and continuation-in-part applications; patents issuing on or claiming priority to any of the
foregoing applications including reissues, reexaminations and extensions; and any corresponding foreign applications or patents relating to the Field of Use. 

1.12 “Technology” shall mean any and all information, know-how, processes, procedures,
compositions, devices, methods, formulas, protocols, techniques, designs, data, and any other material, ideas, inventions, discoveries, whether or not patentable and which is within the scope of the Patent Rights. 

1.13 “Term” shall have the meaning set forth in Section 13.1. 

1.14 “Valid Patent Claim” mean a claim included in (a) an issued and unexpired Patent within the Patent Rights, which has not
been held unenforceable, unpatentable or invalid by an unreversed and unappealable decision of a court or governmental agency of competent jurisdiction, and which has not been admitted to be invalid or unenforceable through reissue, reexamination,
interference or opposition; or (b) a pending patent application which has not yet been abandoned or finally rejected, without the right to appeal, by the United States Patent and Trademark Office or other applicable, analogous foreign
government authority, provided that the claim of substantially the same scope is subsequently granted in such pending patent application. 
 2.
CONSIDERATION 
 2.1 In consideration for the License granted hereunder, Licensee shall issue and deliver to Licensor or its designees, no
later than the Execution Date, 3,520,000 shares of the Licensee’s Common Stock, as provided for in the common stock purchase agreement executed contemporaneously herewith and delivered on the Effective Date. 

3. (Left Blank Intentionally) 
 4. GRANT OF LICENSE 

4.1 Licensor hereby grants to Licensee an exclusive, world-wide, irrevocable (except upon the
termination of this Agreement as provided in this Agreement), non-transferable (except as permitted under Section 14.3), royalty-free license under the Patent
Rights and Improvements to practice methods, have practiced methods, design, have designed, to develop, use, make, have made, import, have imported, export, have exported, sell, have sold, offer to sell, distribute, have distributed, market and
promote, or otherwise dispose of Licensed Products solely in the Field of Use (“Licensed Rights”). 
 4.2 Licensee hereby grants
to Licensor an exclusive, worldwide, perpetual, in evocable, fully-paid-up, royalty-free license under Licensee Improvements to
design, develop, manufacture, use, sell, offer for sale, import, export or otherwise distribute products incorporating such Licensee Improvements outside the Field of Use, including the right to grant sublicenses. 

  
 3 

 4.3 Retained Rights. As between the Parties, Licensor retains all right, title and
interest in and to Licensor’s Intellectual Property Rights (including the Patent Rights) subject to the License and Licensee retains all right, title and interest in and to Intellectual Property Rights in Licensee Improvements subject to the
license under Section 4.2. 
 4.4 Patent Rights Prosecution and Maintenance. 

4.4.1 Notices. Licensor shall keep Licensee reasonably informed of the course and status of prosecution of Patents within the Patent
Rights. In connection therewith, the Parties shall cooperate with regard to prosecution and Licensor shall provide or make available to Licensee copies of any substantive documents that Licensor receives from any patent offices world-wide in the course of such prosecution, including, without limitation, any official actions, responses, notices of interferences, re-examinations, oppositions, or
requests for patent term extensions; sufficiently in advance of any response deadline to permit the Parties to consult and cooperate with regard thereto Licensee may reasonably make recommendations to Licensor concerning such response and/or
documents, and Licensor agrees to reasonably consider such recommendations. 
 4.4.2 Filing, Prosecution, Maintenance of Patent
Rights. The Parties shall consult and cooperate in connection with the preparation, filing, prosecution, and maintenance of the Patent Rights licensed by Licensor to Licensee. Licensor shall, at its expense, prepare, file, prosecute, and
maintain such Patent Rights as it shall determine in its reasonable discretion but with due regard for Licensee’s business interests and recommendations made by Licensee. Licensee may request that Licensor prepare, file, prosecute, and maintain
particular claims within the scope of the Patent Rights, and Licensor will reasonably consider such request; provided that, if Licensor complies with such requests that arc specific to the Licensee, Licensee will pay or reimburse Licensor for all
incremental costs and expenses reasonably incurred by Licensor in connection with implementing such specific request, and Licensee shall have the right to review any such pending applications and other documents filed or received by Licensor in any
related proceedings and make reasonable recommendations to Licensor with respect thereto. 
 5. THIRD PARTY INFRINGEMENT OF THE PATENT RIGHTS 

5.1 Notice of Infringement Claims. Licensor and Licensee each agrees to notify the other in writing of any acts of infringement, claim
of infringement, or suspected infringement of any of the Patent Rights by a third party in the Field of Use promptly after such matters are brought to the attention of the Party giving such notice or it has knowledge hereof Any notice under this
Section 5.1 shall include, without limitation, a statement of the facts that are known by the Party giving the notice and which such Party believes might reasonably serve as a basis for a claim of such infringement, supported by copies of any
pertinent documentation in the possession or control of the Party giving the notice Upon receipt of any notice under this paragraph, the Parties shall consult to determine what, if any action, should be taken on account of the infringement. 

  
 4 

 5.2 Licensee’s First Right of Prosecution. Licensee will have the first right,
but not any obligation, to take any steps, including commencing and prosecuting at its own expense any legal action that it reasonably deems appropriate, against any infringement of the Patent Rights in the Field of Use. If any such steps or any
such legal action is commenced by Licensee with respect to any infringement of the Patent Rights in the Field of Use, the following will apply unless otherwise agreed upon by the Parties: (a) Licensee may, without expense to Licensor, include
Licensor’s name as a party in the action only if required by applicable law to obtain or preserve standing; provided that Licensee holds Licensor harmless against any order for costs that may be made against Licensor in such action, except for
costs arising out of gross negligence or intentional misconduct of Licensor; (b) Licensee will give Licensor written notice of Licensee’s intent to commence the action within a reasonable period (but in no event less than sixty (60)
days) in advance of such commencement; (c) Licensor may, at its option and expense, participate in any such action (e.g., as a party to the action or otherwise), and Licensee shall thereafter reasonably cooperate with Licensor with respect to
such action; (d) Licensee will consult with Licensor and keep Licensor reasonably informed with respect to such action, and will work with Licensor to develop a mutually acceptable mechanism in connection with making any statements, taking any
positions or submitting any briefs regarding the scope, validity and/or enforceability of the Patent Rights; (e) Licensee will provide Licensor such information and copies of any documentation relating to the action as Licensor may reasonably
request; (f) Licensee will not settle or otherwise compromise any such action without Licensor’s prior written consent, such consent not to be unreasonably delayed or withheld; if such settlement or otherwise compromise will reasonably
diminish Licensor’s interest in such Patent Rights; and (g) any recovery in such action will be applied: first to reimbursement of Licensee’s costs and expenses (including, without limitation, any court costs, witness fees, and
attorneys’ fees) reasonably incurred in connection with the action; and second to the reimbursement of Licensor’s costs and expenses (including, without limitation, any court costs, witness fees, and attorneys’ fees) reasonably
incurred in connection with the action, except for costs arising out of gross negligence or intentional misconduct of Licensor. 
 5.3
Licensor’s Second Right of Prosecution. If, within one hundred and eighty (180) days after a written request from Licensor with respect to any infringement of the Licensed Patent Rights in the Field of Use and in accordance to
Section 5.1, Licensee does not reasonably take measures to address the alleged infringement or commence and thereafter reasonably diligently prosecute any legal action against such infringement, then Licensor will have the right, but not any
obligation, to commence and prosecute any legal action that it deems appropriate against such infringement. If any legal action is commenced by Licensor with respect to any infringement of the Patent Rights in the Field of Use, the following will
apply unless otherwise agreed upon by the Parties: (a) Licensor may include Licensee’s name as a party in the action if required by applicable law to obtain or preserve standing; (b) Licensor will give Licensee written notice of
Licensor’s intent to commence the action within a reasonable period (but in no event less than sixty (60) days) in advance of such commencement. Any recovery in such action will be applied: first to reimbursement of Licensor’s costs
and expenses (including, without limitation, any court costs, witness fees, and attorneys’ fees) reasonably incurred in connection with the action, and second to the reimbursement of Licensee’s costs and expenses (including, without
limitation, any court costs, witness fees, and attorneys’ fees) reasonably incurred in connection with the action, except for costs arising out of gross negligence or intentional misconduct of Licensee, with all remainder being retained by
Licensor. Notwithstanding anything to the contrary, neither Party, shall take or withhold from taking any action, alone or as a result of other agreements with any other third parties that would adversely affect or reduce the other Party’s
rights under this Agreement. 

  
 5 

 6. REPRESENTATIONS AND WARRANTIES 

6.1 Licensor Representations. Licensor represents and warrants that: (i) as of the Effective Date, Licensor owns the Patent
Rights, (ii) Licensor does not know as of the Effective Date, of any third party or third parties that claim to own, or hold a license or right to, any Patent Rights; (iii) it has not granted, as of the Effective Date, and, will not,
during the Term of this Agreement, grant licenses or any other rights under the Patents inconsistent with the terms of this Agreement to the extent necessary to fulfill Licensor’s obligations under this Agreement; (iv) that Licensor has
the necessary tight to grant the License in accordance with the terms of this Agreement, provided that the foregoing shall not be deemed a representation regarding noninfringement, (v) as of the Effective Date, the Patents have not been the
subject of any USPTO opposition or interference proceeding or similar acts/actions/procedures in other countries and/or jurisdictions; and (vi) the execution, delivery and performance of this Agreement have been duly authorized by all necessary
corporate or similarly applicable actions on the part of Licensor. Notwithstanding the foregoing, nothing in this Section 6.1 shall be deemed a representation or warranty that the Patent Rights are valid and/or enforceable, or that the practice
of the inventions in the Patent Rights, will not infringe, directly or indirectly, any third party’s Intellectual Property Rights. 

6.2 Licensee Representations. Licensee represents and warrants that: (i) it is a duly organized legal entity, validly existing and
in good standing under the laws of the State of Delaware; (ii) the execution of this Agreement and Licensee’s performance under this Agreement does not and will not violate, conflict with, or result in a material default under any other
agreement to which Licensee is a party; and (iii) the execution, delivery, and performance of this Agreement have been duly authorized by all necessary corporate or similarly applicable actions on the part of Licensee. 

7. INDEMNIFICATION; INSURANCE 
 7.1
Indemnification by Licensee. Licensee shall, at its option and expense, defend or settle any claim, proceeding, or suit (“Claim”) brought by third parties against Licensor, its successors or assigns (collectively, the “Licensor
Indemnitees”), arising from or occurring as a result of the production, manufacture, lease, license, sale or distribution of Licensed Products by Licensee, or any of its Affiliates or sublicensees (“Licensor Claim”) if (a) the
Licensor Indemnitees give Licensee prompt written notice of the Licensor Claim; and (b) Licensee has full and complete control over the defense and settlement of the Licensor Claim; and (c) the Licensor Indemnitees provide assistance, at
Licensee’s expense, in connection with the defense and settlement of the Licensor Claim as Licensee may reasonably request; and (d) the Licensor Indemnitees complies with any settlement or court order made in connection with the Licensor
Claim., Licensee will also indemnify each Licensor Indemnitee against and pay (i) all damages, costs, and attorneys’ fees finally awarded against any Licensor Indemnitee in any Licensor Claim; (ii) reasonable costs (including
reasonable attorneys’ fees) reasonably incurred by any Licensor indemnitee in connection with the defense of such Licensor Claim, including assistance provided to Licensee in accordance with this Section 7.1 (other than attorneys’
fees and costs incurred without Licensee’s consent after Licensee has accepted defense of such Claim); and, (iii) if any Licensor Claim is settled by Licensee, all amounts to be paid to any third party in settlement of any such Claim;
provided that Licensee shall not settle any claim giving rise to an obligation of indemnity under this Section 7.1 without the consent of the affected Licensor Indemnitees unless such settlement involves no more than the payment of money by
Licensee, but in no event shall such consent be unreasonably withheld or delayed unless the same would reasonably be expected to have a material adverse effect on Licensor or the Patent Rights outside the Field of Use. Notwithstanding the foregoing,
Licensee will not be responsible for any Licensor Claim to the extent such Licensor Claim is attributable to (1) the breach or failure to be true of any Licensor representation or warranty contained in this Agreement, (2) the settlement of
a Licensor Claim by any Licensor Indemnitee without the prior written approval of Licensee, the approval of which will not be unreasonably withheld, or (3) gross negligence or any intentional misconduct on by part of Licensor or Licensor
Indemnitees. 

  
 6 

 7.2 Indemnification by Licensor. Licensor shall, at its option and expense, defend or
settle any claim, proceeding, or suit (“Claim”) brought by third parties against Licensee, its successors or assigns (collectively, the “Licensee Indemnitees”), arising from due to any material breach of the representations and
warranties made by the Licensor (“Licensee Claim”) or material breach of any material provisions of this Agreement, if (a) the Licensee has full and complete control over the defense and settlement of the Licensee Claim; (b) the
Licensee Indemnitees provide assistance, at Licensor’s expense, in connection with the defense and settlement of the Licensee Claim as Licensor may reasonably request; and (c) the Licensee Indemnitees complies with any settlement or court
order made in connection with the Licensee Claim. Licensor will also indemnify each Licensee Indemnitee against and pay (i) all damages, costs, and attorneys’ fees finally awarded against any Licensee Indemnitee in any Licensee Claim;
(ii) all reasonable costs (including reasonable attorneys’ fees) reasonably incurred by any Licensee Indemnitee in connection with the defense of such Licensee Claim, including assistance provided to Licensor in accordance with this
Section 7.2 (other than attorneys’ fees and costs incurred without Licensor’s consent after Licensor has accepted defense of such Claim); and, (iii) if any Licensee Claim is settled, all amounts to be paid to any third party in
settlement of any such Claim; provided that Licensor shall not settle any claim giving rise to an obligation of indemnity under this Section 7.2 without the consent of the affected Licensee Indemnitees unless such settlement involves no more
than the payment of money by Licensor, but in no event shall such consent be unreasonably withheld or delayed unless the same would reasonably be expected to have a material adverse effect on Licensee or the nature, scope or any other aspect of the
License or the Patent Rights within the Field of Use, Notwithstanding the foregoing, Licensor will not be responsible for any Licensee Claim to the extent such Licensee Claim is attributable to (1) the breach or failure to be true of any
Licensee representation or warranty contained in this Agreement, or (2) the settlement of a Licensee Claim by any Licensee Indemnitee without the prior written approval of Licensor, the approval of which will not be unreasonably withheld, or
(3) gross negligence or any intentional misconduct on by part of Licensee or Licensee Indemnitees. 
 7.3 Insurance. At all
times during the Term of this Agreement, Licensee will maintain, at its sole cost and expense, Comprehensive General Liability Insurance, including Product Liability Insurance on or before the date the company iniates any test or trial on a human
patient with a reputable and financially secure insurance carrier to cover the activities of Licensee and its sublicensees with minimum limits of liability of $1,000,000.00 each occurrence and will include Licensor as an additional insured.
Insurance must cover claims that arise during the Term of this Agreement and must be placed with a carrier with a rating of at least A- as rated by A M. Best Licensee will furnish a Certificate of Insurance
evidencing primary coverage and additional insured requirements at Licensor’s request. Licensee will provide to Licensor at least thirty (30) days’ prior written notice of cancellation or material change to this insurance coverage.

  
 7 

 8. LIMITATION OF LIABILITY. IN NO EVENT SHALL LICENSOR OR LICENSEE HAVE ANY LIABILITY OR
RESPONSIBILITY FOR ANY SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES, OR FOR LOST PROFITS, IN EACH CASE, REGARDLESS OF THE FORM OF ACTION (WHETHER IN CONTRACT OR IN TORT OR OTHERWISE) ARISING OUT OF OR IN CONNECTION
WITH THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREBY, THE LICENSE PROVIDED HEREIN, THE TECHNOLOGY, THE USE OF THE TECHNOLOGY BY LICENSEE, OR THE MANUFACTURE OR SALE OF LICENSED PRODUCTS. 

9. DISCLAIMER. EXCEPT AS EXPRESSLY PROVIDED IN SECTIONS 6.1, AND 6.2, NEITHER PARTY MAKES ANY WARRANTIES OR CONDITIONS (EXPRESS, IMPLIED,
STATUTORY OR OTHERWISE) WITH RESPECT TO THE SUBJECT MATTER HEREOF, AND EACH PARTY SPECIFICALLY DISCLAIMS ANY AND ALL IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, AND ALL WARRANTIES AND CONDITIONS OF THE
VALIDITY OR ENFORECEABILITY OF THE PATENT RIGHTS CLAIMS, WHETHER ISSUED OR PENDING. NOTHING IN THIS AGREEMENT WILL BE DEEMED A WARRANTY BY LICENSOR THAT THE INFORMATION, TECHNOLOGY OR MATERIALS PROVIDED BY LICENSOR HEREUNDER OR THE EXERCISE OF THE
LICENSE BY LICENSEE OR ITS SUBLICENSEES WILL NOT INFRINGE THE PATENT RIGHTS OF ANY THIRD PARTY. 
 10. TREATMENT OF CONFIDENTIAL INFORMATION 

10.1 For the three (3) year period following the Effective Date, the Receiving Party shall (a) treat the Confidential Information of
the Disclosing Party at a standard of care that such Party treats its own Confidential Information of a similar nature (but in no event, less than reasonable care), and shall take all reasonable steps to (i) prevent unauthorized disclosure or
use of the Disclosing Party’s Confidential Information (and any information derived from such Confidential Information, to the extent such information is Confidential Information), and to (ii) prevent it from falling into the public domain
or the possession of unauthorized persons; (b) use such Confidential Information (and any information derived from such Confidential Information, to the extent such information is Confidential Information) only to perform its obligations and
exercise its rights under this Agreement, and not for any other purposes not expressly permitted under this Agreement; (c) disclose such Confidential Information only to Receiving Party’s employees, employees, agents, consultants,
attorneys, shareholders, accountants, financial advisors or investors and potential investors and acquirers, who (i) are bound by a written confidentiality agreement containing provisions at least as protective of the Disclosing Party’s
rights as those set forth herein and (ii) need access to such Confidential Information solely for purposes of the Receiving Party exercising its rights and performing its obligations hereunder. In addition, Receiving Party may disclose
Disclosing Party’s Confidential Information to the extent necessary to comply with a judicial order, a requirement of a governmental agency, or as otherwise required or necessary by law (e.g., filing of patent applications); provided that
Receiving Party gives Disclosing Party prompt written notice of any such requirement prior to such disclosure, coordinates with Disclosing Party to limit the nature and scope of such required disclosure, and discloses only to the extent necessary to
comply with such order, requirement or law. 

  
 8 

 10.2 Publicity. The Parties each agree not to disclose any terms or conditions of
this Agreement to any third party, except the Parties’ attorneys, accountants, other professional advisors and lenders, shareholders, and potential investors and acquirers, without the prior consent of the other Party, such consent not
unreasonably withheld, except as required by applicable law. 
 10.3 Return of Confidential Information. Immediately upon the
termination of this Agreement, Receiving Party will immediately cease all use of and promptly return to Disclosing Party all tangible copies of Disclosing Party’s Confidential Information and all documents or media containing any such
Confidential Information and any and all extracts thereof. Notwithstanding the above, Licensee shall have the right to maintain such Confidential Information if the Term of the Agreement terminates upon its natural expiration under
Section 13.1. 
 10.4 Injunctive Relief. Receiving Party acknowledges and agrees that, due to the unique nature of Disclosing
Party’s Confidential Information, any breach of its obligations in this Agreement may allow the Receiving Party or third parties to unfairly compete with Disclosing Party resulting in immediate and irreparable harm to Disclosing Party, and that
the remedies at law for any breach may be inadequate. Nothing contained in this Agreement shall be construed as limiting Disclosing Party’s right to any other remedies it may have at law, including, without limitation, the recovery of damages
for breach of this Agreement. 
 11. DISPUTE RESOLUTION 

11.1 Dispute Resolution; Notice. Except for the right of either Party to apply to a court of competent jurisdiction (a) for relief
relating to intellectual property disputes or (b) for a temporary restraining order, a preliminary injunction, or other equitable relief to preserve the status quo, or prevent irreparable harm, or claims limited by the applicable statute of
limitation, any and all claims, disputes or controversies between the Parties arising under, out of, or in connection with the Agreement, which the Parties are unable to resolve shall be mediated in good faith. The Party raising such dispute shall
promptly advise the other of such claim, dispute, or controversy in writing, describing the dispute in reasonable detail. By no later than ten (10) business days after the recipient has received such notice of dispute, each Party shall select a
representative who shall have the authority to bind such Party and shall advise the other Party in writing of the name and title of such representative. 

  
 9 

 11.2 Mediator; Costs. Within thirty (30) days of receipt of a request for
mediation as described above, the Parties agree to commence mediation in a location agreed to by the Parties or, if the Parties are unable to agree, a mutually inconvenient location selected by the American Arbitration Association. The Parties shall
select a mediator acceptable to both of them from a list provided by the American Arbitration Association. The Parties agree to cooperate in good faith in said mediator’s efforts to assist the Parties to resolve the dispute. Each Party agrees
to pay fifty percent (50%) of the costs of said mediation. Decisions of the mediator are not binding unless agreed to by each Party. 
 12. NOTICES

 Any and all notices given under this Agreement shall be in writing and may be affected by personal delivery, facsimile (to be followed
with written facsimile confirmation), commercial overnight delivery providing evidence of receipt; private courier service providing evidence of receipt; or sent by registered or certified, postage prepaid with return receipt requested with evidence
of receipt. Notices shall be sent to the Parties at their respective addresses set forth on the first page of this Agreement and addressed to the appropriate representative of the other Party. Notices shall be deemed given on the day of actual
receipt (or refusal of delivery) when personally delivered; two (2) business days after confirmed transmission when sent by facsimile; two (2) business days after having been sent and delivered by commercial overnight delivery or private
courier service and seven (7) business days after having been mailed when sent by certified or registered mail and proof of such delivery. Each Party may change its mailing address by notifying the other Party in writing of the new address.

 13. TERM AND TERMINATION 
 13.1 This
Agreement will be effective as of the Effective Date and shall expire simultaneously with the cancellation or expiration of the Patents (the “Term”). 

13.2 Termination for Material Breach. In the event Licensee materially breaches any of its obligations under this Agreement, Licensor may
terminate this Agreement upon 60 days’ written notice if the breach remains uncured during such 60 days. 
 13.3 Effect of
Termination. Upon any termination of this Agreement under Section 13.2, as of the effective date of such termination: 
 13.3.1
Termination of this Agreement shall be without prejudice to any remedy, which either Party may have against the other for the breach. 

13.3.2 In the event of any expiration or termination of this Agreement, all rights and licenses granted under this Agreement by either Party,
and all sublicenses granted by Licensee, will immediately terminate. The following provisions shall survive any expiration or termination: Sections 1, 3, 7 (for the period of time set forth therein), 8, 9, 10, 11, 12, 13, and 14.3. All rights
and licenses granted under or pursuant to this Agreement by Licensor are, and shall be deemed to be, for purposes of Section 365(n) of the United States Bankruptcy Code (as amended, the “Code”), licenses to rights to
“intellectual property” as defined under the Code. The Parties agree that in the event of the commencement of a bankruptcy proceeding by or against Licensor under the Code, Licensee, as licensee of intellectual property rights under this
Agreement, shall retain and may fully exercise all of its rights and elections under this Agreement, the Code and otherwise. 

  
 10 

 14. GENERAL PROVISIONS 

14.1 Governing Law. This Agreement shall be construed and enforced in accordance with the laws of the State of California, without
reference to its conflicts of law principles. 
 14.2 Status. Nothing in this Agreement is intended or shall be deemed to constitute
a partner, agency, employer-employee, or joint venture relationship between the Parties. 
 14.3
Assignment. Except as otherwise provided herein, this Agreement and the rights and obligations hereunder may not be transferred or assigned by Licensee or Licensor without the prior written consent of the other Party hereto, which consent
shall not be unreasonably withheld; provided, however that (A) Licensee may, without the Licensor’s prior written consent, assign or transfer this Agreement and its rights and obligations hereunder to a successor of all or substantially
all of Licensee’s assets, stock, or equity, or the business to which this Agreement relates (whether by sale, acquisition, merger, change of control, operation of law or otherwise); provided that Licensee’s successor shall agree in writing
to be bound by all terms and conditions of this Agreement applicable to Licensee and (B) Licensor may, without Licensee’s prior written consent, assign or transfer (a) this Agreement and its rights and obligations hereunder to a
successor of all or substantially all of Licensor’s assets, stock or business to which this Agreement relates (whether by sale, acquisition, merger, change of control, operation of law or otherwise); and (b) all (but not less than all) of
its rights and obligations hereunder to a person or entity who is also the assignee or transferee of the Patent Rights; provided that, Licensor’s assignee, successor or transferee shall agree in writing to be bound by all terms and conditions
of this Agreement applicable to the Licensor. Subject to the foregoing, this Agreement will bind and inure to the benefit of the Parties’ respective heirs, successors, permitted assigns, executors and administrators, as the case may be. 

14.4 Entire Agreement; Amendment. This Agreement and all exhibits attached hereto and being of even date herewith, except as updated
from time-to-time as required under this Agreement, constitute the entire agreement between the Parties with respect to the subject matter hereof and supersede all
proposals, negotiations and other communications between the Parties, whether written or oral, with respect to the subject matter hereof. This Agreement may be amended only by written agreement signed by the Parties. 

14.5 Severability. If any provisions of this Agreement shall be held to be invalid, illegal, or unenforceable, such provisions shall be
limited to the extent permissible so that the validity, legality, and enforceability of the remaining provisions of this Agreement shall not be impaired thereby. 

14.6 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original as against
the Party whose signature appears thereon, but all of which taken together shall constitute but one and the same instrument. 
 14.7
Waiver; Cumulative Remedies. Waiver of any breach of this Agreement by either Party shall be ineffective unless in writing signed by the Party waiving compliance and shall not be considered a waiver of any other breach. All remedies provided
for in this Agreement shall be cumulative and in addition to, and not in lieu of, any other remedies available to either Party at law, in equity of otherwise. 

  
 11 

 14.8 Force Majeure. Except for the payment obligations hereunder, neither Party
hereto shall be liable for failures and delays in performance due to strikes, lockouts, fires, acts of God or the public enemy, riots, incendiaries, interference by civil or military authorities, compliance with the laws of various countries, or
with the orders of any governmental authorities, delays in transit or delivery on the part of transportation companies, failures of communication facilities, or any failure of sources of material, for so long as such events of force majeure remain
in effect. 
 14.9 Headings. The section headings appearing in this Agreement have been inserted as a matter of convenience and in no
way define, limit or enlarge the scope of this Agreement. This Agreement shall be interpreted as written and negotiated jointly by the Parties. It shall not be strictly construed against either Party, regardless of the actual drafter of the
Agreement. 
 14.10 Rights of Prevailing Party. Subject to Section 11.2, in the event any obligation of this Agreement must be
enforced, through litigation or otherwise, the prevailing Party will be entitled to recover reasonable costs and expenses incurred in enforcing the obligation, including costs, reasonable attorneys’ fees and experts’ fees. 

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date last written below. 

 

									
	“Licensor”	 		 	“Licensee”
			
	HERMES, LLC.	 		 	MINERVA SURGICAL, INC.
					
	By:	 	 /s/ Csaba Truckai
	 		 	By:	 	 /s/ Bruno Strul

					
	Name:	 	Csaba Truckai	 		 	Name:	 	Bruno Strul
					
	Title:	 	Managing Member	 		 	Title:	 	Chief Financial Officer
					
	Date:	 	 12/11/08
	 		 	Date:	 	 12/10/08

  
 12 

 EXHIBIT A 

PATENT RIGHTS 
 U S Patent Application
No. 61/196,780 filed Oct 21, 2008 titled “Systems for Tissue Ablation” 

 ADDENDUM TO LICENSE AGREEMENT BETWEEN 

HERMES INNOVATIONS, LLC AND MINERVA SURGICAL, INC. 

This Addendum dated April     , 2009, amends the License Agreement (“Agreement”) beating an
Effective Date of October 31, 2008 by and between HERMES INNOVATIONS, LLC (“HERMES”) and MINERVA SURGICAL, INC. (“Minerva Surgical”) as follows: 

Whereas, HERMES as Licensor under the Agreement agreed to update from time to time the list of patent applications and patents within the
Field of Use that are listed in Exhibit A of the Agreement; 
 Therefore, Revised Exhibit A attached hereto shall replace Exhibit A of
the Agreement in its entirety. 
  

									
		 		 		 	HERMES Innovations, LLC
					
	Date:	 	 9-19-09
	 		 	By:	 	 /s/ Csaba Truckai

		 		 		 	Name:	 	Csaba Truckai
		 		 		 	Title:	 	Managing Partner
				
		 		 		 	MINERVA SURGICAL, INC
					
	Date:	 	 4/20/09
	 		 	By:	 	 /s/ Bruno Strul

		 		 		 	Name:	 	Bruno Strul
		 		 		 	Title:	 	Chief Financial Officer

 REVISED EXHIBIT A 

PATENT RIGHTS 
 U.S. Patent 6,413,256
issued July 2, 2002 titled “Voltage Threshold Ablation Method and Apparatus” 
 U.S. Patent 6,821,275 issued November 23, 2004 titled
“Voltage Threshold Ablation Apparatus” 
 EP Appl. No. 01967968.7 filed August 14, 2001 (Docket
022356-000200EP) titled “Voltage Threshold Ablation Apparatus” 
 Japan Appl No. 2003-524459 filed August 14, 2001 (Docket 022356-000200JP) titled “Voltage Threshold Ablation Apparatus” 

U.S. Patent Application 11/090,706 filed March 24, 2005 titled “Voltage Threshold Ablation Apparatus” 

U.S. Patent 6,890,332 issued May 10, 2005 titled “Electrical Discharge Devices and Techniques for Medical Procedures” 

U.S. Patent 7,220,261 issued May 22, 2007 titled “Electrical Discharge Devices and Techniques for Medical Procedures” 

U.S. Patent Application No 11/300,689 filed December 14, 2005, (Docket No:
S-500-00100A) titled “Supercavitating Medical Probe and Method of Use” 

U.S. Patent Application No. 11/735,318 filed April 13, 2007 titled “Electrical Discharge Devices and Techniques for Medical Procedures”

 U.S. Patent Application 11/649,377 filed Jan. 3, 2007 titled “Electrosurgical Device and Method” 

U.S Patent Application 12/405,025 filed Mar. 17, 2009 titled “Electrosurgical Device and Method” 

U.S. Provisional Patent Application 61/196,870 filed Oct. 21, 2008 titled “Systems for Tissue Ablation”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]